Skip to main content

Table 1 PATH panel

From: Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material

Mutation analysis

Amplification analysis

MSI

AKT1

ALK

55 MSI markers

AKT2

BRAF

 

AKT3

EGFR

 

ALK

ERBB2

 

ARAF

FGFR1

 

BRAF

FGFR2

 

DDR2

FGFR3

 

EGFR

KIT

 

ERBB2

KRAS

 

FGFR1

MDM2

 

FGFR2

MET

 

FGFR3

PDGFRA

 

GNA11

PIK3CA

 

GNAQ

  

GNAS

  

HRAS

  

IDH1

  

IDH2

  

JAK2

  

KIT

  

KRAS

  

MAP2K1

  

MDM2

  

MET

  

MTOR

  

NRAS

  

PDGFRA

  

PIK3CA

  

POLE

  

PTEN

  

RAF1

  

ROS1

  

TP53

  
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us